These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3314623)

  • 1. Thirteenth Daniel C. Baker, Jr, memorial lecture. Monoclonal antibodies: the coming revolution in diagnosis and treatment of human disease.
    Price BJ
    Ann Otol Rhinol Laryngol; 1987; 96(5):497-504. PubMed ID: 3314623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hybridoma technology for the generation of monoclonal antibodies.
    Zhang C
    Methods Mol Biol; 2012; 901():117-35. PubMed ID: 22723097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies based on hybridoma technology.
    Yagami H; Kato H; Tsumoto K; Tomita M
    Pharm Pat Anal; 2013 Mar; 2(2):249-63. PubMed ID: 24237029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Monoclonal antibodies].
    Koyama K
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Aug; 40(8):1044-9. PubMed ID: 3075226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Target therapy of cancer: implementation of monoclonal antibodies and nanobodies.
    Majidi J; Barar J; Baradaran B; Abdolalizadeh J; Omidi Y
    Hum Antibodies; 2009; 18(3):81-100. PubMed ID: 19729803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Historical development of monoclonal antibody therapeutics.
    Nissim A; Chernajovsky Y
    Handb Exp Pharmacol; 2008; (181):3-18. PubMed ID: 18071939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hybridoma technology a versatile method for isolation of monoclonal antibodies, its applicability across species, limitations, advancement and future perspectives.
    Parray HA; Shukla S; Samal S; Shrivastava T; Ahmed S; Sharma C; Kumar R
    Int Immunopharmacol; 2020 Aug; 85():106639. PubMed ID: 32473573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rapid and efficient in vivo method for determining the biologic efficacy of monoclonal antibodies in animal models of cancer.
    Staquet K; Giles-Komar J
    Hybridoma (Larchmt); 2006 Apr; 25(2):68-74. PubMed ID: 16704306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies.
    Ackermann R
    Hum Cell; 1988 Mar; 1(1):46-53. PubMed ID: 3154013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of monoclonal antibodies of desired specificity using chimeric polyomavirus-derived virus-like particles.
    Zvirbliene A; Samonskyte L; Gedvilaite A; Voronkova T; Ulrich R; Sasnauskas K
    J Immunol Methods; 2006 Apr; 311(1-2):57-70. PubMed ID: 16516908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal hybridoma antibodies in human melanoma: current status.
    Burk MW
    Int Adv Surg Oncol; 1984; 7():241-70. PubMed ID: 6205999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Lymphocyte hybridization and cancerology: diagnostic and therapeutic applications. Example of tumor markers].
    Cazin JL; Gosselin P; Demaille A
    Pathol Biol (Paris); 1993 Nov; 41(9):881-6. PubMed ID: 8121720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy for cancer: construction, expression and functional characterization of chimeric antibodies.
    Motmans K; Thirion S; Heyligen H; Janssens J; Raus J; Vandevyver C
    Eur J Cancer Prev; 1996 Dec; 5(6):512-9. PubMed ID: 9061286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hybridoma revolution: an offshoot of basic research.
    Milstein C
    Bioessays; 1999 Nov; 21(11):966-73. PubMed ID: 10517870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hybridoma technology for the generation of rodent mAbs via classical fusion.
    Chronopoulou E; Uribe-Benninghoff A; Corbett CR; Berry JD
    Methods Mol Biol; 2014; 1131():47-70. PubMed ID: 24515459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hybridoma technologies for antibody production.
    Tomita M; Tsumoto K
    Immunotherapy; 2011 Mar; 3(3):371-80. PubMed ID: 21395379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional properties and effect on growth suppression of human neuroblastoma tumors by isotype switch variants of monoclonal antiganglioside GD2 antibody 14.18.
    Mujoo K; Kipps TJ; Yang HM; Cheresh DA; Wargalla U; Sander DJ; Reisfeld RA
    Cancer Res; 1989 Jun; 49(11):2857-61. PubMed ID: 2720646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Monoclonal antibody-based design of antitumor drugs: prerequisites and progress].
    Chmutin EF; Ivanov PK; Baryshnikov AIu
    Vestn Ross Akad Med Nauk; 2004; (12):10-6. PubMed ID: 15678682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New monoclonal antibodies in renal transplantation.
    Vincenti F
    Minerva Urol Nefrol; 2003 Mar; 55(1):57-66. PubMed ID: 12773967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.